Self-assembly delivery system based on small-molecule camptothecin prodrug for treatment of colorectal carcinoma

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1. Hao Y, Chen Y, He X et al. Polymeric nanoparticles with ROS-responsive prodrug and platinum nanozyme for enhanced chemophotodynamic therapy of colon cancer. Adv. Sci. (Weinh.) 7(20), 2001853 (2020).
  Medline CASGoogle Scholar
• 2. Zhang Y, Yin R, Wu G et al. Self-assembling nanoparticles of dually hydrophobic prodrugs constructed from camptothecin analogue for cancer therapy. Eur. J. Med. Chem. 200, 112365 (2020).
  Medline CASGoogle Scholar
• 3. Zhang F, Zhu G, Jacobson O et al. Transformative nanomedicine of an amphiphilic camptothecin prodrug for long circulation and high tumor uptake in cancer therapy. ACS Nano 11(9), 8838–8848 (2017). • Shows the strategy of transformative nanomedicine is promising for efficient drug delivery.
  Medline CASGoogle Scholar
• 4. Sun Y, Liang Y, Hao N et al. Novel polymeric micelles as enzyme-sensitive nuclear-targeted dual-functional drug delivery vehicles for enhanced 9-nitro-20(S)-camptothecin delivery and antitumor efficacy. Nanoscale 12(9), 5380–5396 (2020).
  Medline CASGoogle Scholar
• 5. Fassberg J, Stella VJ. A kinetic and mechanistic study of the hydrolysis of camptothecin and some analogues. J. Pharm. Sci. 81(7), 676–684 (1992).
  Medline CASGoogle Scholar
• 6. Hertzberg RP, Caranfa MJ, Holden KG et al. Modification of the hydroxy lactone ring of camptothecin: inhibition of mammalian topoisomerase I and biological activity. J. Med. Chem. 32(3), 715–720 (1989).
  Medline CASGoogle Scholar
• 7. Burke TG, Mi Z. The structural basis of camptothecin interactions with human serum albumin: impact on drug stability. J. Med. Chem. 37(1), 40–46 (1994).
  Medline CASGoogle Scholar
• 8. Drummond DC, Noble CO, Guo Z, Hong K, Park JW, Kirpotin DB. Development of a highly active nanoliposomal irinotecan using a novel intraliposomal stabilization strategy. Cancer Res. 66(6), 3271–3277 (2006).
  Medline CASGoogle Scholar
• 9. Liu Z, Robinson JT, Sun X, Dai H. PEGylated nanographene oxide for delivery of water-insoluble cancer drugs. J. Am. Chem. Soc. 130(33), 10876–10877 (2008).
  Medline CASGoogle Scholar
• 10. He Q, Shi J, Chen F, Zhu M, Zhang L. An anticancer drug delivery system based on surfactant-templated mesoporous silica nanoparticles. Biomaterials 31(12), 3335–3346 (2010).
  Medline CASGoogle Scholar
• 11. Li J, Zhu Y, Li W, Zhang X, Peng Y, Huang Q. Nanodiamonds as intracellular transporters of chemotherapeutic drug. Biomaterials 31(32), 8410–8418 (2010).
  Medline CASGoogle Scholar
• 12. Page SM, Martorella M, Parelkar S, Kosif I, Emrick T. Disulfide cross-linked phosphorylch-oline micelles for triggered release of camptothecin. Mol. Pharm. 10(7), 2684–2692 (2013).
  MedlineGoogle Scholar
• 13. Li Y, Lu H, Liang S, Xu S. Dual stable nanomedicines prepared by cisplatin-crosslinked camptothecin prodrug micelles for effective drug delivery. ACS Appl. Mater. Interfaces 11(23), 20649–20659 (2019).
  Medline CASGoogle Scholar
• 14. Matsumura Y. Preclinical and clinical studies of NK012, an SN-38-incorporating polymeric micelles, which is designed based on EPR effect. Adv. Drug Deliv. Rev. 63(3), 184–192 (2011).
  Medline CASGoogle Scholar
• 15. Modi S, Xiang TX, Anderson BD. Enhanced active liposomal loading of a poorly soluble ionizable drug using supersaturated drug solutions. J. Control. Release 162(2), 330–339 (2012).
  Medline CASGoogle Scholar
• 16. Li X, Chen Y, Wang M, Ma Y, Xia W, Gu H. A mesoporous silica nanoparticle–PEI–fusogenic peptide system for siRNA delivery in cancer therapy. Biomaterials 34(4), 1391–1401 (2013).
  Medline CASGoogle Scholar
• 17. Zhang H, Wang J, Mao W et al. Novel SN38 conjugate-forming nanoparticles as anticancer prodrug: in vitro and in vivo studies. J. Control. Release 166(2), 147–158 (2013).
  Medline CASGoogle Scholar
• 18. Bala V, Rao S, Boyd BJ, Prestidge CA. Prodrug and nanomedicine approaches for the delivery of the camptothecin analogue SN38. J. Control. Release 172(1), 48–61 (2013).
  Medline CASGoogle Scholar
• 19. Fugit KD, Anderson BD. The role of pH and ring-opening hydrolysis kinetics on liposomal release of topotecan. J. Control. Release 174, 88–97 (2014).
  Medline CASGoogle Scholar
• 20. Bai S, Gao YE, Ma X et al. Reduction stimuli-responsive unimolecular polymeric prodrug based on amphiphilic dextran-framework for antitumor drug delivery. Carbohydr. Polym. 182, 235–244 (2018).
  Medline CASGoogle Scholar
• 21. Hu X, Liu R, Zhang D, Zhang J, Li Z, Luan Y. Rational design of an amphiphilic chlorambucil prodrug realizing self-assembled micelles for efficient anticancer therapy. ACS Biomater. Sci. Eng. 4(3), 973–980 (2018).
  Medline CASGoogle Scholar
• 22. He W, Hu X, Jiang W et al. Rational design of a new self-codelivery system from redox-sensitive camptothecin-cytarabine conjugate assembly for effectively synergistic anticancer therapy. Adv. Healthc. Mater. 6(24), 1700829 (2017).
  Google Scholar
• 23. He D, Zhang W, Deng H et al. Self-assembling nanowires of an amphiphilic camptothecin prodrug derived from homologous derivative conjugation. Chem. Commun. (Camb.) 52(98), 14145–14148 (2016).
  Medline CASGoogle Scholar
• 24. Dong S, He J, Sun Y et al. Efficient click synthesis of a protonized and reduction-sensitive amphiphilic small-molecule prodrug containing camptothecin and gemcitabine for a drug self-delivery system. Mol. Pharm. 16(9), 3770–3779 (2019).
  Medline CASGoogle Scholar
• 25. Shen YQ, Jin EL, Zhang B et al. Prodrugs forming high drug loading multifunctional nanocapsules for intracellular cancer drug delivery. J. Am. Chem. Soc. 132(12), 4259–4265 (2010).
  Medline CASGoogle Scholar
• 26. Cheetham AG, Zhang PC, Lin YA et al. Supramolecular nanostructures formed by anticancer drug assembly. J. Am. Chem. Soc. 135(17), 2907–2910 (2013).
  Medline CASGoogle Scholar
• 27. Huang P, Wang D, Su Y et al. Combination of small molecule prodrug and nanodrug delivery: amphiphilic drug-drug conjugate for cancer therapy. J. Am. Chem. Soc. 136(33), 11748–11756 (2014).
  Medline CASGoogle Scholar
• 28. Xu Y, Huang Y, Zhang X, Lu W, Yu J, Liu S. Carrier-free Janus nano-prodrug based on camptothecin and gemcitabine: reduction-triggered drug release and synergistic in vitro antiproliferative effect in multiple cancer cells. Int. J. Pharm. 550(1–2), 45–56 (2018).
  Medline CASGoogle Scholar
• 29. Li F, Huang Z, Chen H et al. Redox-sensitive lipophilic prodrugs: delivering unstable chemotherapeutant for improved cancer therapy. Drug Deliv. 26(1), 1068–1079 (2019).
  Medline CASGoogle Scholar
• 30. Luo C, Sun J, Liu D et al. Self-assembled redox dual-responsive prodrug-nanosystem formed by single thioether-bridged paclitaxel-fatty acid conjugate for cancer chemotherapy. Nano Lett. 16(9), 5401–5418 (2016). • Demonstrates that small-molecule prodrug nanosystem could be a promising strategy for efficient anticancer drug delivery.
  Medline CASGoogle Scholar
• 31. Luo C, Sun J, Sun B et al. Facile fabrication of tumor redox-sensitive nanoassemblies of small-molecule oleate prodrug as potent chemotherapeutic nanomedicine. Small 12(46), 6353–6362 (2016). •• Demonstrates that redox-responsive prodrug nanosystem exhibits multiple therapeutic advantages, including one-step facile fabrication, high drug loading efficiency (56% w/w), on-demand drug release responding to redox stimuli and favorable cellular uptake and biodistribution.
  Medline CASGoogle Scholar
• 32. Mou Q, Ma Y, Zhu X, Yan D. A small molecule nanodrug consisting of amphiphilic targeting ligand-chemotherapy drug conjugate for targeted cancer therapy. J. Control. Release 230, 34–44 (2016).
  Medline CASGoogle Scholar
• 33. Sharma S, Verma A, Singh J et al. Vitamin B6 tethered endosomal pH responsive lipid nanoparticles for triggered intracellular release of doxorubicin. ACS Appl. Mater. Interfaces 8(44), 30407–30421 (2016). •• Demonstrates that vitamin B6-coupled molecules are more easily internalized by tumor cells via vitamin B6 transporting membrane carrier (VTC).
  Medline CASGoogle Scholar
• 34. Banerjee S, Dixit A, Karande AA, Chakravarty AR. Endoplasmic reticulum targeting tumour selective photocytotoxic oxovanadium(IV) complexes having vitamin-B6 and acridinyl moieties. Dalton Trans. 45(2), 783–796 (2016). • Discusses how vitamin B6 has been reported to play an important protective role against various diseases and cancers via its antioxidation, antiangiogenesis and anti-inflammatory effects.
  Medline CASGoogle Scholar
• 35. Yanaka N, Kanda M, Toya K, Suehiro H, Kato N. Vitamin B6 regulates mRNA expression of peroxisome proliferator-activated receptor-γ target genes. Exp. Ther. Med. 2(3), 419–424 (2011).
  Medline CASGoogle Scholar
• 36. Pandey S, Garg P, Lim KT et al. The efficiency of membrane transport of vitamin B6 coupled to poly(ester amine) gene transporter and transfection in cancer cells. Biomaterials 34(14), 3716–3728 (2013).
  Medline CASGoogle Scholar
• 37. Huang Y, Zhang W, Xu Y et al. Dynamic core crosslinked camptothecin prodrug micelles with reduction sensitivity and boronic acid-mediated enhanced endocytosis: an intelligent tumor-targeted delivery nanoplatform. Int. J. Pharm. 580, 119250 (2020).
  Medline CASGoogle Scholar
• 38. He W, Jiang Y, Li Q, Zhang D, Li Z, Luan Y. A versatile strategy to create an active tumor-targeted chemo-photothermal therapy nanoplatform: a case of an IR-780 derivative co-assembled with camptothecin prodrug. Acta Biomater. 84, 356–366 (2019).
  Medline CASGoogle Scholar
• 39. Li Y, Liu R, Yang J, Ma G, Zhang Z, Zhang X. Dual sensitive and temporally controlled camptothecin prodrug liposomes codelivery of siRNA for high efficiency tumor therapy. Biomaterials 35(36), 9731–9745 (2014).
  Medline CASGoogle Scholar
• 40. Landgraf M, Lahr CA, Kaur I et al. Targeted camptothecin delivery via silicon nanoparticles reduces breast cancer metastasis. Biomaterials 240, 119791 (2020). • Camptothecin (CPT)-loaded porous silicon nanoparticles (pSiNPs) showed significant therapeutic effect on breast cancer metastasis in vivo.
  Medline CASGoogle Scholar
• 41. Wang G, Zhou Z, Zhao Z et al. Enzyme-triggered transcytosis of dendrimer-drug conjugate for deep penetration into pancreatic tumors. ACS Nano 14(4), 4890–4904 (2020).
  Medline CASGoogle Scholar
• 42. Zhang Y, Yang D, Chen H et al. Reduction-sensitive fluorescence enhanced polymeric prodrug nanoparticles for combinational photothermal-chemotherapy. Biomaterials 163, 14–24 (2018).
  Medline CASGoogle Scholar
• 43. Qu Y, Chu B, Wei X et al. Redox/pH dual-stimuli responsive camptothecin prodrug nanogels for “on-demand” drug delivery. J. Control. Release 296, 93–106 (2019).
  Medline CASGoogle Scholar
• 44. Cedervall T, Lynch I, Foy M et al. Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. Angew. Chem. Int. Ed. Engl. 46(30), 5754–5756 (2007).
  Medline CASGoogle Scholar
• 45. Ju Y, Dai Q, Cui J et al. Improving targeting of metal-phenolic capsules by the presence of protein coronas. ACS Appl. Mater. Interfaces 8(35), 22914–22922 (2016).
  Medline CASGoogle Scholar